Medicine & Life Sciences

1. Glioblastoma 100%
2. Bevacizumab 40%
3. Survival 38%
4. Glioma 36%
5. Temozolomide 34%
6. Databases 32%
7. Neoplasms 28%
8. Irinotecan 20%
9. Acquired Immunodeficiency Syndrome 14%
10. Therapeutics 12%
11. Reoperation 12%
12. Brain 12%
13. Electrodes 12%
14. HIV 12%
15. Drug Therapy 12%
16. Artificial Intelligence 11%
17. Geographic Locations 11%
18. Fibroblast Growth Factor Receptors 11%
19. Drug Approval 11%
20. Progression-Free Survival 11%
21. Central Nervous System Neoplasms 10%
22. Mutation 10%
23. United States Food and Drug Administration 9%
24. Radiosurgery 9%
25. Needle Biopsy 9%
26. Meningioma 9%
27. Robotics 9%
28. Retrospective Studies 9%
29. Medicare 9%
30. Electronic Health Records 8%
31. CD4 Lymphocyte Count 8%
32. Safety 8%
33. Radiation 8%
34. Electroencephalography 8%
35. Brain Neoplasms 8%
36. Recurrence 8%
37. Survival Analysis 8%
38. Lung Neoplasms 7%
39. Cerebrospinal Fluid 7%
40. Seizures 7%
41. Datasets 7%
42. Diffuse Intrinsic Pontine Glioma 7%
43. Cognitive Dysfunction 7%
44. Lasers 7%
45. Breast Neoplasms 7%
46. Hispanic Americans 6%
47. Hot Temperature 6%
48. Weights and Measures 6%
49. Biopsy 6%
50. Patient Readmission 6%